课题基金 / 基金详情

DETERMINATION OF FIRST PASS INTESTINAL METABOLISM OF MIDAZOLAM IN HUMAN SUBJECTS

DETERMINATION OF FIRST PASS INTESTINAL METABOLISM OF MIDAZOLAM IN HUMAN SUBJECTS
咪达唑仑在人体中首过肠道代谢的测定
批准号:
6115617
负责人:
ALASTAIR J. J. WOOD
金额:
$3.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

ALASTAIR J. J. WOOD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To estimate the intestinal contribution to the first pass metabolism of orally administered midazolam. The hypothesis is that midazolam is metabolized by intestinal cytochrome P450 3 A (P450 3A) enzymes to a clinical significant amount. To measure the effect of P450 3A inhibition by orally administered ketoconazole on the pharmacokinetic parameters of orally and intravenously administered midazolam. The hypothesis is that oral ketoconazole affects the disposition of the oral dose more than that of the intravenous midazolam. Preliminary analysis has shown some racial differences in the metabolism of midazolam. Continued analysis will determine to what extent the significance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MDR-1-INHIBITION AND CYP3A ACTIVITY
  • 批准号:
    7375662
  • 项目类别:
  • 资助金额:
    $1.43万
  • 财政年份:
    2005
  • 负责人:
    ALASTAIR J. J. WOOD
  • 依托单位:
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY
  • 批准号:
    7375600
  • 项目类别:
  • 资助金额:
    $4.91万
  • 财政年份:
    2005
  • 负责人:
    ALASTAIR J. J. WOOD
  • 依托单位:
EFFECT OF INHIBITION OF P-GLYCOPROTEIN BY XR-9576 ON THE CENTRAL OPIOID ACTIV
  • 批准号:
    7207235
  • 项目类别:
  • 资助金额:
    $7.09万
  • 财政年份:
    2004
  • 负责人:
    ALASTAIR J. J. WOOD
  • 依托单位:
PHYSIOLOGY AND PHARMACOLOGY OF A-ADRENERGIC RECEPTOR VARIABILITY
  • 批准号:
    7207237
  • 项目类别:
  • 资助金额:
    $6.08万
  • 财政年份:
    2004
  • 负责人:
    ALASTAIR J. J. WOOD
  • 依托单位:
海外基金